Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.

Based on Aalto University and VTT research, IQM Quantum Computers has lured investors including Tencent to bring its equity and grant funding total to $83.9m.

Julius-Maximilians-University of Würzburg's cancer immunotherapy developer Catalym plans to move its lead asset into the clinic next month.

CIC and Parkwalk have returned to back patient-focused genomic analysis developer Congenica, bringing its funding total to $85m.

Cambridge Innovation Capital has backed a round sized at up to $50m for disease testing kit producer Sense Biodetection, which has now raised more than $64m altogether.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

University of Colorado and Osage University Partners both backed a round that took the immune regulation-focused university spinout's total funding to at least $106m.

The bioremediation technology startup is the first company to be launched through MIT spinout Ginkgo Bioworks' $350m Ferment Consortium.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

Main Sequence Ventures, which co-founded the meat-free burger producer last year, has returned for a $55m series B round.